Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 44)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 New Constructs, LLC N/A BMRN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: BIOMARIN PHARM -- BMRN 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BMRN , CRXL , NPSP , PGNX , RIGL , ZGEN -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMARIN PHARMACEUTICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
18-Nov-09 Thomson StreetEvents N/A BMRN - Event Transcript of BioMarin Pharmaceutical Inc. conference call, Nov. 11, 2009 / 12:00pm ET 8 $75 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOMARIN PHARMACEUTICAL INC 5 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 10 of 16)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
18-Nov-09 Thomson StreetEvents N/A BMRN - Event Transcript of BioMarin Pharmaceutical Inc. conference call, Nov. 11, 2009 / 12:00pm ET 8 $75 View Abstract
10-Nov-09 Thomson StreetEvents N/A BMRN - Event Transcript of BioMarin Pharmaceutical Inc. conference call, Nov. 03, 2009 / 1:35pm ET 9 $75 View Abstract
4-Nov-09 Thomson StreetEvents N/A BMRN - Event Transcript of BioMarin Pharmaceutical Inc. conference call, Oct. 28, 2009 / 5:00pm ET 27 $75 View Abstract
4-Nov-09 Thomson StreetEvents N/A BMRN - Event Brief of BioMarin Pharmaceutical Inc. conference call, Oct. 28, 2009 / 5:00pm ET 29 $75 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 20 $50 View Abstract
29-Oct-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD BMRN: Reports 3Q09 Results 4 $10 View Abstract
29-Oct-09 Brean Murray & Co., Inc. Eric M. Beder, Jonathan M. Aschoff PhD, Andrey Glukhov CFA, Daniel Fidell, Bret Jones, Ananda Baruah Morning Insight (TLEO, BMRN, ITRI, CNP, ARW, EFII, CERN, NWY) 11 $25 View Abstract
29-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA 3Q09 EPS; Cost Controls and Kuvan Lead to EPS Upside 7 $25 View Abstract
29-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino BMRN Smashes Q3 EPS Expectations 6 $25 View Abstract
27-Oct-09 Thomson StreetEvents N/A BMRN - Event Transcript of BioMarin Pharmaceutical Inc. conference call, Oct. 26, 2009 / 2:30pm ET 16 $75 View Abstract
Next 6

Independent Reports (Showing 1 to 10 of 28)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 New Constructs, LLC N/A BMRN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: BIOMARIN PHARM -- BMRN 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BMRN , CRXL , NPSP , PGNX , RIGL , ZGEN -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMARIN PHARMACEUTICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
19-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
15-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOMARIN PHARMACEUTICAL INC 5 $25 View Abstract
12-Nov-09 Rapid Ratings Rapid Ratings BIOMARIN PHARMACEUTICAL INC rated sell (2009-11-12) (US$665) 8 $665 View Abstract
Next 18

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.